Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors

Molecular Brain Research

Volumn 117, Issue 2, 2003, Pages 196-205

  Blaabjerg, Morten ^a   Baskys, Andrius ^b,c   Zimmer, Jens ^a   Vawter, Marquis P ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cDNA microarray; DHPG; Excitatory amino acids: excitotoxicity; Hippocampus; mGluR; Neuroprotection; Neurotransmitters, modulators, transporters, and receptors; Organotypic slice culture

Indexed keywords

3,5 DIHYDROXYPHENYLGLYCINE; COMPLEMENTARY DNA; GUANOSINE TRIPHOSPHATASE; METABOTROPIC RECEPTOR 1; RAB PROTEIN; RAB5 PROTEIN; RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA TRANSCRIPTION; DOWN REGULATION; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENE FUNCTION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; METHOXYHYDROXYPHENYLGLYCOL; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RAB5 GTP-BINDING PROTEINS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 1642340475     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00321-8     Document Type: Article

References (55)

1. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
2. Vornov J.J., Tasker R.C., Coyle J.T. Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke. 25:1994;457-464.
3. Krystal J.H., Anand A., Moghaddam B. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch. Gen. Psychiatry. 59:2002;663-664.
4. M. Blaabjerg, Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents, Exp. Neurol., in press.
5. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130:2000;1007S-1015S.
6. Mao L., Wang J.Q. Group I metabotropic glutamate receptor-mediated calcium signalling and immediate early gene expression in cultured rat striatal neurons. Eur. J. Neurosci. 17:2003;741-750.
7. Vawter M.P., Barrett T., Cheadle C., Sokolov B.P., Wood W.H. III, Donovan D.M., Webster M., Freed W.J., Becker K.G. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55:2001;641-650.
8. Baldi P., Long A.D. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 17:2001;509-519.
9. de Hoop M.J., Huber L.A., Stenmark H., Williamson E., Zerial M., Parton R.G., Dotti C.G. The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis. Neuron. 13:1994;11-22.
10. Zerial M., McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2:2001;107-117.
11. Man H.Y., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron. 25:2000;649-662.
12. Roche K.W., Standley S., McCallum J., Dune L.C., Ehlers M.D., Wenthold R.J. Molecular determinants of NMDA receptor internalization. Nat. Neurosci. 4:2001;794-802.
13. Snyder E.M., Philpot B.D., Huber K.M., Dong X., Fallon J.R., Bear M.F. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4:2001;1079-1085.
14. Schroder U.H., Opitz T., Jager T., Sabelhaus C.F., Breder J., Reymann K.G. Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C. Neuropharmacology. 38:1999;209-216.
15. A. Arnett, L. Fang, R. Vu, C. Reist, A. Baskys, Inhibition of DHPG-induced neuroprotection with antisense oligonucleotides against RAB5B, Soc. Neurosci. Abstr. (2003).
16. Contractor A., Swanson G.T., Sailer A., O'Gorman S., Heinemann S.F. Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 20:2000;8269-8278.
17. Contractor A., Swanson G., Heinemann S.F. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron. 29:2001;209-216.
18. Bavro V.N., Sola M., Bracher A., Kneussel M., Betz H., Weissenhorn W. Crystal structure of the GABA(A)-receptor-associated protein, GABARAP. EMBO Rep. 3:2002;183-189.
19. Coyle J.E., Qamar S., Rajashankar K.R., Nikolov D.B. Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding. Neuron. 33:2002;63-74.
20. Kennedy M.B. Sticking together. Proc. Natl. Acad. Sci. USA. 97:2000;11135-11136.
21. Feuerstein G.Z., Wang X., Barone F.C. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann. N. Y. Acad. Sci. 825:1997;179-193.
22. Zhao B., Schwartz J.P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52:1998;7-16.
23. Petitto J.M., Huang Z., Raizada M.K., Rinker C.M., McCarthy D.B. Molecular cloning of the cDNA coding sequence of IL-2 receptor-gamma (gammac) from human and murine forebrain: expression in the hippocampus in situ and by brain cells in vitro. Brain Res. Mol. Brain Res. 53:1998;152-162.
24. Ye J.H., Tao L., Zalcman S.S. Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons. Brain Res. 894:2001;241-248.
25. Brunetti L. Nitric oxide: a gas as a modulator of neuroendocrine secretions. Clin. Ter. 144:1994;147-153.
26. Dommergues M.A., Patkai J., Renauld J.C., Evrard P., Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann. Neurol. 47:2000;54-63.
27. Aplin A.E., Howe A., Alahari S.K., Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50:1998;197-263.
28. Pinkstaff J.K., Detterich J., Lynch G., Gall C. Integrin subunit gene expression is regionally differentiated in adult brain. J. Neurosci. 19:1999;1541-1556.
29. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:1996;697-715.
30. Chavis P., Westbrook G. Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature. 411:2001;317-321.
31. Schlaepfer D.D., Hunter T. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol. 8:1998;151-157.
32. Skaper S.D., Facci L., Strijbos P.J. Neuronal protein kinase signaling cascades and excitotoxic cell death. Ann. N. Y. Acad. Sci. 939:2001;11-22.
33. Murai K.K., Misner D., Ranscht B. Contactin supports synaptic plasticity associated with hippocampal long-term depression but not potentiation. Curr. Biol. 12:2002;181-190.
34. Fankhauser C., Friedlander R.M., Gagliardini V. Prevention of nuclear localization of activated caspases correlates with inhibition of apoptosis. Apoptosis. 5:2000;117-132.
35. Blake D.J., Hawkes R., Benson M.A., Beesley P.W. Different dystrophin-like complexes are expressed in neurons and glia. J. Cell Biol. 147:1999;645-658.
36. Grady R.M., Grange R.W., Lau K.S., Maimone M.M., Nichol M.C., Stull J.T., Sanes J.R. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1:1999;215-220.
37. Koshimura K., Tanaka J., Murakami Y., Kato Y. Involvement of nitric oxide in glucose toxicity on differentiated PC12 cells: prevention of glucose toxicity by tetrahydrobiopterin, a cofactor for nitric oxide synthase. Neurosci. Res. 43:2002;31-38.
38. Heneka M.T., Loschmann P.A., Gleichmann M., Weller M., Schulz J.B., Wullner U., Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J. Neurochem. 71:1998;88-94.
39. Vige X., Carreau A., Scatton B., Nowicki J.P. Antagonism by NG-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy. Neuroscience. 55:1993;893-901.
40. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
41. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N-methyl-D-aspartate neurotoxicity. Brain Res. 625:1993;337-341.
42. Farinelli S.E., Park D.S., Greene L.A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci. 16:1996;2325-2334.
43. Maiese K., Boniece I., DeMeo D., Wagner J.A. Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13:1993;3034-3040.
44. Hu M.C., Qiu W.R., Wang X., Meyer C.F., Tan T.H. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes Dev. 10:1996;2251-2264.
45. Luo Y., Umegaki H., Wang X., Abe R., Roth G.S. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem. 273:1998;3756-3764.
46. Israel D.I., Nove J., Kerns K.M., Kaufman R.J., Rosen V., Cox K.A., Wozney J.M. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors. 13:1996;291-300.
47. Charytoniuk D.A., Traiffort E., Pinard E., Issertial O., Seylaz J., Ruat M. Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia. Neuroscience. 100:2000;33-43.
48. Melnick M., Chen H., Min Z.Y., Jaskoll T. The functional genomic response of developing embryonic submandibular glands to NF-kappaB inhibition. BMC Dev. Biol. 1:2001;15.
49. English J.D., Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272:1997;19103-19106.
50. Hou S.T., Callaghan D., Fournier M.C., Hill I., Kang L., Massie B., Morley P., Murray C., Rasquinha I., Slack R., MacManus J.P. The transcription factor E2F1 modulates apoptosis of neurons. J. Neurochem. 75:2000;91-100.
51. Gendron T.F., Mealing G.A., Paris J., Lou A., Edwards A., Hou S.T., MacManus J.P., Hakim A.M., Morley P. Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F1 knockout mice. J. Neurochem. 78:2001;316-324.
52. Liu D.X., Greene L.A. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron. 32:2001;425-438.
53. Hatfield G.W., Hung S.P., Baldi P. Differential analysis of DNA microarray gene expression data. Mol. Microbiol. 47:2003;871-877.
54. Bucci C., Lutcke A., Steele-Mortimer O., Olkkonen V.M., Dupree P., Chiariello M., Bruni C.B., Simons K., Zerial M. Co-operative regulation of endocytosis by three Rab5 isoforms. FEBS Lett. 366:1995;65-71.
55. Callaghan J., Nixon S., Bucci C., Toh B.H., Stenmark H. Direct interaction of EEA1 with Rab5b. Eur. J. Biochem. 265:1999;361-366.